SCHEMBL4649097

SCHEMBL4649097

NC(=O)c1cc([N+](=O)[O-])ccc1OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.60
KMT2A Q03164 5/20 0.60
MAPT P10636 2/20 0.60
CYP19A1 P11511 6/20 0.58
PKM P14618 1/20 0.56
ALDH1A1 P00352 2/20 0.55
CYP1A2 P05177 1/20 0.55
POLB P06746 1/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
CTSV O60911 2/20 0.55
CTSL P07711 2/20 0.55
CYP11B1 P15538 2/20 0.53
CYP11B2 P19099 2/20 0.53
GAA P10253 1/20 0.51
PPIA P62937 1/20 0.51
AKR1C3 P42330 1/20 0.50
PARP1 P09874 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1319458 0.89 CTSV (0.63) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL18153986 0.87 CYP19A1 (0.54) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL4412940 0.87 MAOB (0.51) MEN1KMT2AMAPTCYP19A1PKM
SCHEMBL20581857 0.86 KMT2A (0.58) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL9157553 0.86 MEN1 (0.62) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL6567396 0.85 MEN1 (0.64) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL2297894 0.84 MEN1 (0.66) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL22117864 0.83 MEN1 (0.62) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL31174832 0.83 MEN1 (0.62) MEN1KMT2AMAPTCYP19A1ALDH1A1
SCHEMBL3949981 0.83 MEN1 (0.58) MEN1KMT2AMAPTCYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963292-A2 ORGANIC COMPOUNDS Novartis Pharma AG (CH) 2008-09-03 EP disclosed
WO-2007067615-A2 THIADIAZOLE DERIVATIVES AS ANTIDIABETIC AGENTS NOVARTIS AG (CH) 2007-06-14 WO disclosed